Amgen Inc. (AMGN) Financial News - S&P 500 Analyst Recommendation Changes for Aug. 17

Amgen Inc. (AMGN)

S&P 500 Analyst Recommendation Changes for Aug. 17

Quote: 12-Daily Change-2011201120112011 PercentLevel ================================================================================ Wellpoint Inc4. JPMorgan Chase & Co4.704.654.654.651.1%0.05 CIGNA Corp3.953.913.913.911.0%0.04 MetroPCS Communications3.973.933.933.931.0%0.04 AT&T Inc4. Amgen Inc4. Starwood Hotels & Resorts4. Time Warner Cable4.284.244.374.370.9%0.04 Host Hotels & Resorts3.713.683.683.680.8%0.03 Medco Health Solutions3.893.863.863.830.8%0.03 Nabors Industries3.973.943.943.940.8%0.03 Broadcom Corp-Cl A4.324. Forest Laboratories3.573.553.553.620.6%0.02 Cliffs Natural Resources4.614.594.594.590.4%0.02 MEMC Electronic Materials3. Comcast Corp-Class A4. Centurylink Inc4.364.354.354.430.2%0.01 ================================================================================Aug. 17Aug. 16Aug. 15Aug. 12-Daily Change-SOURCE: Bloomberg ...
Open whole article (external link)

Other Financial and Stock Market News concerning Amgen Inc.

Amgen Inc. Stock Summary

Amgen, Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology. The company’s principal products include Aranesp and EPOGEN that stimulate the production of red blood cells to treat anemia; Neulasta and NEUPOGEN, which selectively stimulate the production of neutrophils, a type of white blood cell that helps the body fight infections; and ENBREL that blocks the biologic activity of tumor necrosis factor by inhibiting TNF, a substance induced in response to inflam...